Risk of Medication Errors with IV Pumps

Medication administration errors are among the most vexing and costly events in health care. A therapeutic infusion is intended to help the patient, but sadly patient harm through error can swiftly displace the intended therapeutic effect, which may result in disruption of therapeutic regimen, over- or underdosing leading to loss of intended therapeutic effect, debilitating injury, or even death. In 2020, the Institute for Safe Medication Practices (ISMP) published ISMP Guidelines for Optimizing Safe Implementation and Use of Smart Infusion Pumps. Compiled and reviewed by many clinical experts, this resource outlines the components necessary for developing an organizational infrastructure that promotes safe patient care through the application of smart infusion pump technology. In this session, we will explore the interface between the infusion pump and the nurse (the interface between device and human) as well as the realm in which critical decisions are made and presumptive actions performed; and how successful or deleterious outcomes are initiated.

Learning Objectives:
At the conclusion of this session, participants will be able to:
• Describe the role of smart infusion pumps in optimizing medication safety during medication infusions
• Discuss the risks and benefits of using smart infusion pumps for medication administration
• Explain how to improve the utilization of smart infusion pump technology in the healthcare setting

Evan Frasure, PharmD, BCPS

Evan S. Frasure III, PharmD, BCPS, is the Director for Controlled Substance Diversion Prevention for Duke University Health System, where he oversees the diversion prevention efforts across Duke Health. Dr. Frasure graduated from pharmacy school at Idaho State University in 2007 and completed a PGY1 residency at Carolinas Medical Center – NorthEast in Concord, NC. He has held various positions during his time at Duke, including continuity of care, administration, and business services oversight. He started in his current role in March 2017. In this role, he has implemented staff education modules, a diversion oversight committee, and updated policies & procedures and an analytics software program. Many of these changes have been the result of learning from Drug Enforcement Administration (DEA) settlements.

Only available as part of a package

Key:

Complete
Failed
Available
Locked
Risk of Medication Errors with IV Pumps
Live event: 10/27/2022 at 1:00 PM (EDT) You must register to access.
Session Evaluation
The purpose of the Education Program Evaluation is to enable INS to evaluate each educational session and provide feedback to the speaker. You must register to access.
Certificate
You must register to access.